Genomic and Transcriptomic Changes in Early Gastric Cancer Inform Clinical Risk Stratification Prior to Endoscopic Resection
Cancer Medicine · 2026-11 · 15 (11)
DOI: 10.1002/cam4.72407 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Medicine, online erschienen am 20.11.2026. Verfasst von Jaeyun Jung und 6 weiteren Autor:innen. Die Arbeit nennt 64 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Ministry of Science and ICT, South Korea.
Abstract (Originalsprache)
Purpose
To characterize genomic and transcriptomic features associated with established clinicopathologic risk categories in patients with dysplasia and early gastric cancer (EGC) undergoing endoscopic submucosal dissection (ESD) and to explore molecular correlates of noncurative resection and metachronous recurrence. Materials and Methods A prospective cohort study was conducted involving 99 patients with EGC or dysplasia who underwent ESD at a tertiary care center. Pre‐ESD biopsy samples were subjected to whole‐exome sequencing (WES) and whole‐transcriptome sequencing (WTS). Clinicopathologic data and molecular profiles were analyzed to identify molecular features associated with curative resection and metachronous recurrence.
Results
Of the 99 patients enrolled in the study, 85 were diagnosed with early gastric cancer (EGC) and 14 with dysplasia. Among the 85 patients, 43 (50.6%) met absolute curative criteria, 28 (32.9%) met expanded criteria, and 14 (16.5%) were classified as noncurative. Genomic analysis revealed distinct mutation patterns associated with clinicopathologic risk categories, including recurrent mutations in KRAS and TP53 . Transcriptomic profiling identified 186 differentially expressed genes (DEGs) related to noncurative resection, with enrichment in pathways involving extracellular matrix remodeling, immune signaling, and cell migration. Metachronous recurrence occurred in 6 of the 85 patients (7.1%). Exploratory transcriptomic analyses identified enrichment of inflammatory and immune‐related pathways, including NF‐κB and IL6‐JAK‐STAT3 signaling in tumors from patients who subsequently developed metachronous recurrence. Diffuse‐type EGC showed enhanced epithelial‐mesenchymal transition and matrix remodeling compared to intestinal type.
Conclusion
Integrating genomic and transcriptomic data with clinicopathologic features provides additional insight into the molecular characteristics associated with established risk categories in EGC. These findings expand our understanding of the molecular heterogeneity of EGC and provide a foundation for future studies evaluating the clinical utility of molecular profiling in larger independent cohorts.
Förderung
- Ministry of Science and ICT, South Korea
Zitieren
APA
Jung, J., An, M., Lim, S. H., Kim, S. T., Lee, J., Klempner, S. J., & Lee, H. (2026). Genomic and Transcriptomic Changes in Early Gastric Cancer Inform Clinical Risk Stratification Prior to Endoscopic Resection. Cancer Medicine, 15(11). https://doi.org/10.1002/cam4.72407
Vancouver
Jung J, An M, Lim SH, Kim ST, Lee J, Klempner SJ, et al. Genomic and Transcriptomic Changes in Early Gastric Cancer Inform Clinical Risk Stratification Prior to Endoscopic Resection. Cancer Medicine. 2026;15(11). doi:10.1002/cam4.72407
BibTeX
@article{Jung2026,
author = {Jung, Jaeyun and An, Minae and Lim, Sung Hee and Kim, Seung Tae and Lee, Jeeyun and Klempner, Samuel J. and Lee, Hyuk},
title = {Genomic and Transcriptomic Changes in Early Gastric Cancer Inform Clinical Risk Stratification Prior to Endoscopic Resection},
journal = {Cancer Medicine},
year = {2026},
volume = {15},
number = {11},
doi = {10.1002/cam4.72407}
}
EUVIMED